Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Organogenesis Inc.

    NASDAQ: ORGO · Real-Time Price · USD
    3.03
    0.15 (5.21%)
    At close: Jun 06, 2025, 3:59 PM

    Organogenesis Statistics

    Share Statistics

    Organogenesis has 126.85M shares outstanding. The number of shares has increased by -4.33% in one year.

    Shares Outstanding

    n/a
    		 126.85M

    Shares Change (YoY)

    n/a
    		 -4.33%

    Shares Change (QoQ)

    n/a
    		 0.88%

    Owned by Institutions (%)

    n/a
    		 47.19%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 31,776

    FTD / Avg. Volume

    n/a
    		 2.16%

    Short Selling Information

    The latest short interest is 12.1M, so 9.54% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 12.1M

    Short % of Shares Out

    n/a
    		 9.54%

    Short % of Float

    n/a
    		 27.75%

    Short Ratio (days to cover)

    n/a
    		 4.76

    Valuation Ratios

    The PE ratio is 489.38 and the forward PE ratio is 14.4. Organogenesis's PEG ratio is -3.87.

    PE Ratio

    n/a
    		 489.38

    Forward PE

    n/a
    		 14.4

    PS Ratio

    n/a
    		 0.87

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 1.09

    P/FCF Ratio

    n/a
    		 100.9

    PEG Ratio

    n/a
    		 -3.87
    Financial Ratio History

    Enterprise Valuation

    Organogenesis has an Enterprise Value (EV) of 329.1M.

    EV / Sales

    n/a
    		 0.68

    EV / EBITDA

    n/a
    		 20.88

    EV / EBIT

    n/a
    		 23.16

    EV / FCF

    n/a
    		 78.81

    Financial Position

    The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.11.

    Current Ratio

    n/a
    		 3.69

    Quick Ratio

    n/a
    		 3.35

    Debt / Equity

    n/a
    		 0.11

    Debt / EBITDA

    n/a
    		 2.75

    Debt / FCF

    n/a
    		 10.37

    Interest Coverage

    n/a
    		 -0.83

    Financial Efficiency

    Return on Equity is 0.22% and Return on Invested Capital is 0.09%.

    Return on Equity

    n/a
    		 0.22%

    Return on Assets

    n/a
    		 0.17%

    Return on Invested Capital

    n/a
    		 0.09%

    Revenue Per Employee

    n/a
    		 $554,710.01

    Profits Per Employee

    n/a
    		 $990.79

    Employee Count

    n/a
    		 869

    Asset Turnover

    n/a
    		 0.97

    Inventory Turnover

    n/a
    		 4.41

    Taxes

    Income Tax

    n/a
    		 -3.67M

    Effective Tax Rate

    n/a
    		 130.67%

    Stock Price Statistics

    The stock price has increased by 10.18% in the last 52 weeks. The beta is 1.64, so Organogenesis's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.64

    52-Week Price Change

    n/a
    		 10.18%

    50-Day Moving Average

    n/a
    		 3.88

    200-Day Moving Average

    n/a
    		 3.59

    Relative Strength Index (RSI)

    n/a
    		 41.38

    Average Volume (20 Days)

    n/a
    		 1,469,990

    Income Statement

    In the last 12 months, Organogenesis had revenue of 482.04M and earned 861K in profits. Earnings per share was -0.01.

    Revenue

    n/a
    		 482.04M

    Gross Profit

    n/a
    		 366.3M

    Operating Income

    n/a
    		 -1.28M

    Net Income

    n/a
    		 861K

    EBITDA

    n/a
    		 15.76M

    EBIT

    n/a
    		 -1.26M

    Earnings Per Share (EPS)

    n/a
    		 -0.01
    Full Income Statement

    Balance Sheet

    The company has 135.57M in cash and 43.31M in debt, giving a net cash position of 92.26M.

    Cash & Cash Equivalents

    n/a
    		 135.57M

    Total Debt

    n/a
    		 43.31M

    Net Cash

    n/a
    		 92.26M

    Retained Earnings

    n/a
    		 -40.11M

    Total Assets

    n/a
    		 467.39M

    Working Capital

    n/a
    		 203.11M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 14.21M and capital expenditures -10.03M, giving a free cash flow of 4.18M.

    Operating Cash Flow

    n/a
    		 14.21M

    Capital Expenditures

    n/a
    		 -10.03M

    Free Cash Flow

    n/a
    		 4.18M

    FCF Per Share

    n/a
    		 0.03
    Full Cash Flow Statement

    Margins

    Gross margin is 75.99%, with operating and profit margins of -0.27% and 0.18%.

    Gross Margin

    n/a
    		 75.99%

    Operating Margin

    n/a
    		 -0.27%

    Pretax Margin

    n/a
    		 -0.58%

    Profit Margin

    n/a
    		 0.18%

    EBITDA Margin

    n/a
    		 3.27%

    EBIT Margin

    n/a
    		 -0.27%

    FCF Margin

    n/a
    		 0.87%

    Dividends & Yields

    ORGO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.2%

    FCF Yield

    n/a
    		 0.99%
    Dividend Details

    Analyst Forecast

    The average price target for ORGO is $5.5, which is 81.5% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $5.5

    Price Target Difference

    n/a
    		 81.5%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 0.66

    Graham Upside

    n/a
    		 -78.22%

    Scores

    Altman Z-Score

    n/a
    		 3.34

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist